Acute respiratory viral adverse events during use of antirheumatic disease therapies: A scoping review
Adam Kilian, Yu Pei Eugenia Chock, Irvin J. Huang, Elizabeth R. Graef, Laura Upton, Aneka Khilnani, Sonia D. Silinsky Krupnikova, Ibrahim Almaghlouth, Laura C. Cappelli, Ruth Fernandez‐Ruiz, Brittany A. Frankel, Jourdan Frankovich, Carly Harrison, Bharat Kumar, Kanika Monga, Jorge A. Rosario Vega, Namrata Singh, Jeffrey A. Sparks, Elaine Sullo, Kristen Young, Alí Duarte‐García, Michael Putman, Sindhu R. Johnson, Rebecca Grainger, Zachary S. Wallace, Jean W. Liew, Aruni Jayatilleke
Topics & Concepts
MedicineLeflunomideHydroxychloroquineAzathioprineAdverse effectTocilizumabApremilastSulfasalazineIntensive care medicineRespiratory tract infectionsDiseaseInternal medicineImmunologyRheumatoid arthritisRespiratory systemInfectious disease (medical specialty)Psoriatic arthritisCoronavirus disease 2019 (COVID-19)Ulcerative colitisRespiratory viral infections researchCOVID-19 Clinical Research StudiesRheumatoid Arthritis Research and Therapies